Physiology and pathophysiology of proteinase-activated receptors (PARs): Regulation of the expression of PARs

Journal of Pharmacological Sciences

Volumn 97, Issue 1, 2005, Pages 31-37

  Hirano, Katsuya ^a   Yufu, Tatsuya ^a   Hirano, Mayumi ^a   Nishimura, Junji ^a   Kanaide, Hideo ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Expression; Proteinase activated receptor; Trafficking; Transcription

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; DEXAMETHASONE; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROGESTERONE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ATHEROSCLEROSIS; DEGENERATIVE DISEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HEPATITIS; HUMAN; HUMAN CELL; INTERNALIZATION; KIDNEY TRANSPLANTATION; LYSOSOME; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; RAT; RECEPTOR DOWN REGULATION; SHORT SURVEY; TRANSCRIPTION REGULATION; VIRUS INFECTION;

EID: 14644435041     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FMJ04005X6     Document Type: Short Survey

References (61)

1. Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev. 2002;54:203-217.
2. Kawabata A. PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med. 2002;4:1-17.
3. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev. 2001;53:245-282.
4. Hirano K, Kanaide H. Role of protease-activated receptors in the vascular system. J Atheroscler Thromb. 2003;10:211-225.
5. Cocks TM, Moffatt JD. Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci. 2000;21:103-108.
6. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
7. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol. 1998;274:C1429-C1452.
8. Brass LF, Hoxie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost. 1993;70:217-223.
9. Shapiro MJ, Trejo J, Zeng D, Coughlin SR. Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J Biol Chem. 1996;271:32874-32880.
10. Marchese A, Chen C, Kim YM, Benovic JL. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci. 2003;28:369-376.
11. Trejo J. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther. 2003;307:437-442.
12. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993;268:13756-13763.
13. Woolkalis MJ, DeMelfi Jr TM, Blanchard N, Hoxie JA, Brass LF. Regulation of thrombin receptors on human umbilical vein endothelial cells. J Biol Chem. 1995;270:9868-9875.
14. Shapiro MJ, Coughlin SR. Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor 1. J Biol Chem. 1998;273:29009-29014.
15. 2+ transients and nitric oxide production in endothelial cells ex vivo. Br J Pharmacol. 2000;130:1140-1146.
16. Nakayama T, Hirano K, Shintani Y, Nishimura J, Nakatsuka A, Kuga H, et al. Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells. Br J Pharmacol. 2003;138:121-130.
17. Shintani Y, Hirano K, Nishimura J, Nakano H, Kanaide H. Enhanced contractile response to thrombin in the pregnant rat myometrium. Br J Pharmacol. 2000;131:1619-1628.
18. Li F, Baykal D, Horaist C, Yan C-N, Carr BN, Rao GN, et al. Cloning and identification of regulatory sequences of the human thrombin receptor gene. J Biol Chem. 1996;271:26320-26328.
19. Schmidt VA, Nierman WC, Maglott DR, Cupit LD, Moskowitz KA, Wainer JA, et al. The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem. 1998;273:15061-15068.
20. Schmidt VA, Vitale E, Bahou WF. Genomic cloning and characterization of the human thrombin receptor gene. J Biol Chem. 1996;271:9307-9312.
21. Madamanchi NR, Hu ZY, Li F, Horaist C, Moon SK, Patterson C, et al. A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis. Biochim Biophys Acta. 2002;1576:237-245.
22. i-linked Ras/mitogen-activated protein kinase pathway. J Biol Chem. 1999;274:13718-13727.
23. Wu Y, Ruef J, Rao GN, Patterson C, Runge MS. Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells. Biochem J. 1998;330:1469-1474.
24. Tellez C, McCarty M, Ruiz M, Bar-Eli M. Loss of activator protein-2α results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem. 2003;278:46632-46642.
25. Paing MM, Stutts AB, Kohout TA, Lefkowitz RJ, Trejo J. β-Arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J Biol Chem. 2002; 277:1292-1300.
26. Trejo J, Coughlin SR. The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J Biol Chem. 1999;274:2216-2224.
27. Paing MM, Tem ple BRS, Trejo J. A Tyrosine-based sorting signal regulates intracellular trafficking of protease-activated receptor-1: multiple regulatory mechanisms for agonist-induced G protein-coupled receptor internalization. J Biol Chem. 2004; 279:21938-21947.
28. Wang Y, Zhou Y, Szabo K, Haft CR, Trejo J. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol Biol Cell. 2002;13:1965-1976.
29. Roosterman D, Schmidlin F, Bunnett NW. Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. Am J Physiol. 2003;284:C1319-C1329.
30. Izumi G, Sakisaka T, Baba T, Tanaka S, Morimoto K, Takai Y. Endocytosis of E-cadherin regulated by Rac and Cdc42 small G proteins through IQGAP1 and actin filaments. J Cell Biol. 2004;166:237-248.
31. Rochdi MD, Laroche G, Dupre E, Giguere P, Lebel A, Watier V, et al. Nm23-H2 interacts with a G protein-coupled receptor to regulate its endocytosis through an Rac1-dependent mechanism. J Biol Chem. 2004;279:18981-18989.
32. Shinohara T, Suzuki K, Takada K, Okada M, Ohsuzu F. Regulation of proteinase-activated receptor 1 by inflammatory mediators in human vascular endothelial cells. Cytokine. 2002;19:66-75.
33. Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol. 1996;166:561-567.
34. Mbebi C, Rohn T, Doyennette MA, Chevessier F, Jandrot-Perrus M, Hantai D, et al. Thrombin receptor induction by injury-related factors in human skeletal muscle cells. Exp Cell Res. 2001;263:77-87.
35. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res. 2001;89:92-98.
36. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem. 1996;271:14910-14915.
37. AB. Circulation. 1997;96:3888-3896.
38. Colognato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T, Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood. 2003;102:2645-2652.
39. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation. 1999;99: 2590-2597.
40. Herkert O, Kuhl H, Sandow J, Busse R, Schini-Kerth VB. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation. 2001;104:2826-2831.
41. Wilcox J, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer D, et al. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res. 1994;75:1029-1038.
42. Damiano BP, D'Andrea MR, de Garavilla L, Cheung WM, Andrade-Gordon P. Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemost. 1999;81:808-814.
43. Rohatgi T, Henrich-Noack P, Sedehizade F, Goertler M, Wallesch CW, Reymann KG, et al. Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J Neurosci Res. 2004;75:273-279.
44. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci. 2001;14:595-608.
45. Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett. 2002; 329:181-184.
46. Nguyen KT, Eskin SG, Patterson C, Runge MS, McIntire LVIMLV. Shear stress reduces protease activated receptor-1 expression in human endothelial cells. Ann Biomed Engineering. 2001;29:145-152.
47. Papadaki M, Ruef J, Nguyen KT, Li F, Patterson C, Eskin SG, et al. Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells. Circ Res. 1998;83:1027-1034.
48. Nguyen KT, Frye SR, Eskin SG, Patterson C, Runge MS, McIntire LVIMLV. Cyclic strain increases protease-activated receptor-1 expression in vascular smooth muscle cells. Hypertension. 2001;38:1038-1043.
49. Rohatgi T, Sedehizade F, Sabel BA, Reiser G. Protease-activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J Neurosci Res. 2003;73:246-254.
50. Citron BA, Smirnova IV, Arnold PM, Festoff BW. Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury. J Neurotraum. 2000;17:1191-1203.
51. Niclou SP, Suidan HS, Pavlik A, Vejsada R, Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci. 1998;10:1590-1607.
52. Wang J, Zheng H, Ou X, Fink LM, Hauer-Jensen M. Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol. 2002;160:2063-2072.
53. Miotto D, Hollenberg MD, Bunnett NW, Papi A, Braccioni F, Boschetto P, et al. Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers. Thorax. 2002;57:146-151.
54. Ku DD, Dai J. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. J Cardiovasc Pharmacol. 1997;30:649-657.
55. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90:1614-1621.
56. Salcedo RM, Festoff BW, Citron BA. Quantitative reverse transcriptase PCR to gauge increased protease-activated receptor 1 (PAR-1) mRNA copy numbers in the Wobbler mutant mouse. J Mol Neurosci. 1998;10:113-119.
57. Festoff BW, D'Andrea MR, Citron BA, Salcedo RM, Smirnova IV, Andrade-Gordon P. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin. Mol Med. 2000;6:410-429.
58. Marra F, DeFranco R, Grappone C, Milani S, Pinzani M, Pellegrini G, et al. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology. 1998;27:462-471.
59. Lan RS, Stewart GA, Goldie RG, Henry PJ. Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice. Am J Physiol. 2004; 286:L388-L398.
60. Wang Y-P, Gu Y, Lucas MJ. Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2002;87:3728-3734.
61. Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation. 2001;72:1437-1443.